SCM

Silverarc Capital Management Portfolio holdings

AUM $489M
This Quarter Return
+25.14%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$178M
AUM Growth
+$178M
Cap. Flow
+$8.85M
Cap. Flow %
4.96%
Top 10 Hldgs %
33.95%
Holding
106
New
24
Increased
27
Reduced
29
Closed
17

Top Buys

1
ACRS icon
Aclaris Therapeutics
ACRS
$8.49M
2
RACB
Research Alliance Corp. II Class A Common Stock
RACB
$5.13M
3
MRUS icon
Merus
MRUS
$5.11M
4
MSACU
Medicus Sciences Acquisition Corp. Unit
MSACU
$4.01M
5
ALDX icon
Aldeyra Therapeutics
ALDX
$3.82M

Top Sells

1
VCEL icon
Vericel Corp
VCEL
$8.84M
2
EPIX icon
ESSA Pharma
EPIX
$7.25M
3
STRO icon
Sutro Biopharma
STRO
$4.02M
4
DCTH icon
Delcath Systems
DCTH
$3.87M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.57M

Sector Composition

1 Healthcare 88.22%
2 Financials 2.87%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
COGT icon
51
Cogent Biosciences
COGT
$1.83B
$1.05M 0.57%
120,000
-115,066
-49% -$1.01M
CLRB icon
52
Cellectar Biosciences
CLRB
$15.3M
$976K 0.53%
2,021
-3,888
-66% -$1.88M
AKRO icon
53
Akero Therapeutics
AKRO
$3.65B
$928K 0.51%
32,000
-3,179
-9% -$92.2K
UTHR icon
54
United Therapeutics
UTHR
$17.7B
$897K 0.49%
5,364
– –
MRTX
55
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$857K 0.47%
5,000
-15,000
-75% -$2.57M
IMVT icon
56
Immunovant
IMVT
$2.91B
$808K 0.44%
50,400
-49,600
-50% -$795K
ISEE
57
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$804K 0.44%
130,043
– –
SURF
58
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$780K 0.43%
100,000
-30,000
-23% -$234K
SGEN
59
DELISTED
Seagen Inc. Common Stock
SGEN
$694K 0.38%
5,000
-2,509
-33% -$348K
KALA icon
60
KALA BIO
KALA
$105M
$689K 0.38%
2,046
– –
CGEN icon
61
Compugen
CGEN
$133M
$644K 0.35%
75,000
-75,550
-50% -$649K
TRIL
62
DELISTED
Trillium Therapeutics Inc.
TRIL
$644K 0.35%
60,000
-50,000
-45% -$537K
OTIC
63
DELISTED
Otonomy, Inc.
OTIC
$640K 0.35%
250,995
-12,956
-5% -$33K
APTO
64
DELISTED
Aptose Biosciences, Inc.
APTO
$598K 0.33%
+222
New +$598K
MREO
65
Mereo BioPharma
MREO
$275M
$590K 0.32%
175,000
-105,000
-38% -$354K
LPTX icon
66
Leap Therapeutics
LPTX
$12M
$570K 0.31%
30,000
+2,500
+9% +$47.5K
BLRX
67
BioLineRX
BLRX
$15.5M
$558K 0.3%
+5,000
New +$558K
TVTX icon
68
Travere Therapeutics
TVTX
$1.75B
$499K 0.27%
+20,000
New +$499K
DCTH icon
69
Delcath Systems
DCTH
$381M
$497K 0.27%
40,000
-311,616
-89% -$3.87M
IMTX icon
70
Immatics
IMTX
$662M
$469K 0.26%
+41,797
New +$469K
VRDN icon
71
Viridian Therapeutics
VRDN
$1.59B
$461K 0.25%
+27,586
New +$461K
SNDX icon
72
Syndax Pharmaceuticals
SNDX
$1.39B
$447K 0.24%
20,000
-10,000
-33% -$224K
RCKT icon
73
Rocket Pharmaceuticals
RCKT
$358M
$444K 0.24%
10,000
– –
MDNA
74
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$439K 0.24%
107,536
– –
PNT
75
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$420K 0.23%
40,000
+991
+3% +$10.4K
1 2
3
4 5